TRIR: A Potential Drug Target for Neurological Disorders (G79002)

Target Name: TRIR

NCBI ID: G79002

TRIR

TRIR: A Potential Drug Target for Neurological Disorders

TRIR (tercir) is a protein that is expressed in the brain and is known for its role in the regulation of cell death. It is a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease.

The discovery of TRIR comes from a study by researchers at the University of California, San Diego, who used a technique called RNA-based screening to identify the protein in the brain. They found that TRIR was expressed in the brain and was involved in the regulation of cell death.

This finding is significant because it suggests that TRIR may be a useful target for the treatment of neurological disorders. \"This protein could be a promising drug target for the treatment of Alzheimer's disease and other neurological disorders,\" said Dr. Xinran Li, a researcher at the University of California, San Diego.

In addition to its potential use as a drug target, TRIR has also been identified as a potential biomarker for the diagnosis and monitoring of neurological disorders. This is because the protein is expressed in the brain and can be easily measured using techniques such as RNA sequencing.

TRIR's role in the regulation of cell death is also of interest for its potential use as a therapeutic agent. \"We are interested in using TRIR as a therapeutic agent to protect against neurodegeneration,\" said Dr. Li.

The study by Li and his colleagues has important implications for the treatment of neurological disorders. Their findings suggest that TRIR may be a valuable target for the development of new therapies for a variety of neurological disorders, including Alzheimer's disease.

In conclusion, TRIR is a protein that has the potential to be a drug target and biomarker for the treatment of neurological disorders. Further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: Telomerase RNA Component Interacting RNase

Functions: Exoribonuclease that is part of the telomerase RNA 3' end processing complex and which has the ability to all four unpaired RNA nucleotides from 5' end or 3' end with higher efficiency for purine bases (PubMed:28322335)

The "TRIR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets